Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025

Medicinal Chemicals and Botanical Products

        

Wholesale Biomass (B2B)

- - 11Cr 14Cr 11Cr

Total Assets

- - 22Cr 24Cr 25Cr

Interest Expense

- - -24.86T -92T -31.83L

EBT

- - 3.71Cr 4.78Cr 1.94Cr

Gross Profit

- - 5.82Cr 7.21Cr 4.82Cr

D&A

- - 1.11Cr 1.17Cr 1.24Cr

Operating Income

- - 3.75Cr 4.8Cr 2.2Cr

Wholesale CPG (B2B)

- - 1.61Cr 1.8Cr 1.95Cr

Total Assets

- - 1.28Cr 1.26Cr 1.76Cr

Interest Expense

- - -12.55T -22T -1L

EBT

- - -21.56L 22.6L 39.23L

Gross Profit

- - 12.23L 45.17L 54.65L

D&A

- - 7L 8L 9L

Operating Income

- - -18.58L 23.31L 25.64L

The Production and Sale of Cannabis Products

6.94Cr 9.09Cr - - -

Total Assets

29Cr 35Cr - - -

Interest Expense

-27.37L -76.08L - - -

Income Tax Expense

32.98L 47.42L - - -

CAPEX

-11Cr -2.78Cr - - -

EBT

-4.11Cr -3.09Cr - - -

Gross Profit

1.6Cr 2.15Cr - - -

D&A

47.67L 1.23Cr - - -

Operating Income

-3.51Cr -4.99Cr - - -

Net Income

-4.42Cr -3.55Cr - - -

Drug Stores and Pharmacies

        

Retail (B2C)

- - 3.91Cr 4.38Cr 4.82Cr

Total Assets

- - 2.71Cr 2.62Cr 1.84Cr

Interest Expense

- - -96.48T -2L -1L

EBT

- - 50.05L 40.62L 83.39L

Gross Profit

- - 2.16Cr 2.08Cr 2.33Cr

D&A

- - 13.11L 15.09L 14.64L

Operating Income

- - 53.64L 38.16L 59.21L

Operating Income

- - -9.05Cr -4.84Cr -4.7Cr

D&A

- - 14.58L 10.18L 10.1L

Interest Expense

- - -96.85L -89.11L -36.35L

EBT

- - -13Cr -4.29Cr -4.87Cr

Total Assets

- - 4.39Cr 3.61Cr 3.34Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025

United States of America

6.94Cr 9.09Cr 16Cr 20Cr 18Cr

Total Assets

29Cr 35Cr 30Cr 31Cr 32Cr

Interest Expense

-27.37L -76.08L -98.19L -91.84L -70.58L

Income Tax Expense

32.98L 47.42L 99.43L 1.05Cr 1.19Cr

D&A

47.67L 1.23Cr 1.46Cr 1.5Cr 1.58Cr

CAPEX

-11Cr -2.78Cr -1.23Cr -1.03Cr -2.72Cr

Gross Profit

1.6Cr 2.15Cr 8.1Cr 9.74Cr 7.7Cr

Net Income

-4.42Cr -3.55Cr -9.83Cr 5L -2.97Cr

EBT

-4.11Cr -3.09Cr -8.81Cr 1.12Cr -1.7Cr

Operating Income

-3.51Cr -4.99Cr -4.95Cr 57.37L -1.65Cr